Stocksigma LogoStocksigma Logo

Pine Labs Reports Nil Deviation in Q2FY27 IPO Proceeds Utilization

CARE Ratings confirmed that Pine Labs Limited had zero deviation from stated objects in the utilization of its ₹2,080.00 crore IPO proceeds for the quarter

Pine Labs Reports Nil Deviation in Q2FY27 IPO Proceeds Utilization

Pine Labs Ltd · Others (Uncategorized) · 29 Oct 2026, 11:24 pm

Pine Labs Reports Nil Deviation in Q2FY27 IPO Proceeds Utilization CARE Ratings confirmed that Pine Labs Limited had zero deviation from stated objects in the utilization of its ₹2,080.00 crore IPO proceeds for the quarter ended 30th Sep'26. The company utilized ₹118.31 crore during Q2FY27 entirely toward IT assets, cloud infrastructure, DCP procurements, and tech development initiatives, bringing cumulative utilization to ₹1,093.26 crore. Unutilized proceeds stood at ₹986.74 crore, predominantly parked in bank fixed deposits yielding 6.15% to 6.40% (₹974.00 crore), alongside monitoring and public offer account balances totaling ₹12.74 crore.

Original exchange filing (PDF)

More announcements from Pine Labs Ltd

All Pine Labs Ltd announcements